A detailed history of Teza Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Teza Capital Management LLC holds 42,569 shares of ABT stock, worth $4.86 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
42,569
Previous 80,133 46.88%
Holding current value
$4.86 Million
Previous $8.33 Million 41.71%
% of portfolio
0.54%
Previous 1.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $3.76 Million - $4.44 Million
-37,564 Reduced 46.88%
42,569 $4.85 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $8.07 Million - $9.01 Million
80,133 New
80,133 $8.33 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $2.24 Million - $2.74 Million
-24,854 Reduced 32.68%
51,189 $5.63 Million
Q3 2023

Feb 22, 2024

SELL
$95.53 - $114.62 $2.78 Million - $3.33 Million
-29,064 Reduced 37.55%
48,335 $4.68 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $5.23 Million - $6.27 Million
-54,707 Reduced 41.84%
76,043 $7.36 Million
Q2 2023

Feb 22, 2024

BUY
$100.78 - $112.29 $1.65 Million - $1.84 Million
16,403 Added 26.89%
77,399 $8.44 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $3 Million - $3.34 Million
29,753 Added 29.46%
130,750 $14.3 Million
Q1 2023

Feb 22, 2024

BUY
$96.86 - $114.01 $949,906 - $1.12 Million
9,807 Added 19.16%
60,996 $6.18 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $8.32 Million - $9.8 Million
85,934 Added 570.5%
100,997 $10.2 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $370,068 - $434,147
-3,893 Reduced 20.54%
15,063 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $505,958 - $585,804
5,229 Added 38.09%
18,956 $1.83 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $64,610 - $78,093
-633 Reduced 4.41%
13,727 $1.49 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $950,698 - $1.16 Million
8,338 Added 138.46%
14,360 $1.7 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $82,835 - $101,426
-717 Reduced 10.64%
6,022 $848,000
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $786,171 - $869,735
6,739 New
6,739 $796,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $439,663 - $517,546
-4,156 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $452,339 - $532,923
4,156 New
4,156 $498,000
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $341,908 - $415,222
-3,731 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $285,682 - $365,638
3,731 New
3,731 $341,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $998,013 - $1.2 Million
-16,412 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $2.94 Million - $3.25 Million
-51,121 Reduced 75.7%
16,412 $1 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $3.8 Million - $4.3 Million
67,533 New
67,533 $4.05 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.